Daratumumab induces mechanisms of immune activation through CD38+NK cell targeting
- 15 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 35 (1), 189-200
- https://doi.org/10.1038/s41375-020-0810-4
Abstract
Daratumumab (Dara), a multiple myeloma (MM) therapy, is an antibody against the surface receptor CD38, which is expressed not only on plasma cells but also on NK cells and monocytes. Correlative data have highlighted the immune-modulatory role of Dara, despite the paradoxical observation that Dara regimens decrease the frequency of total NK cells. Here we show that, despite this reduction, NK cells play a pivotal role in Dara anti-MM activity. CD38 on NK cells is essential for Dara-induced immune modulation, and its expression is restricted to NK cells with effector function. We also show that Dara induces rapid CD38 protein degradation associated with NK cell activation, leaving an activated CD38-negative NK cell population. CD38+ NK cell targeting by Dara also promotes monocyte activation, inducing an increase in T-cell costimulatory molecules (CD86/80) and enhancing anti-MM phagocytosis activity ex vivo and in vivo. In support of Dara's immunomodulating role, we show that MM patients that discontinued Dara therapy because of progression maintain targetable unmutated surface CD38 expression on their MM cells, but retain effector cells with impaired cellular immune function. In summary, we report that CD38+ NK cells may be an unexplored therapeutic target for priming the immune system of MM patients.Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (NIH-2-R01-CA201382, P30CA033572)
- U.S. Department of Health & Human Services | National Institutes of Health
This publication has 32 references indexed in Scilit:
- Targeting CD38 with Daratumumab Monotherapy in Multiple MyelomaThe New England Journal of Medicine, 2015
- Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumabLeukemia, 2015
- ADP-ribose/TRPM2-mediated Ca2+ signaling is essential for cytolytic degranulation and antitumor activity of natural killer cellsScientific Reports, 2015
- Daratumumab and its potential in the treatment of multiple myeloma: overview of the preclinical and clinical developmentTherapeutic Advances in Hematology, 2015
- CD38 Controls the Innate Immune Response against Listeria monocytogenesInfection and Immunity, 2013
- Mice Deficient in CD38 Develop an Attenuated Form of Collagen Type II-Induced ArthritisPLOS ONE, 2012
- Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1Journal of Leukocyte Biology, 2011
- Efficiency of T‐cell costimulation by CD80 and CD86 cross‐linking correlates with calcium entryImmunology, 2009
- IFN-γ Arms Human Dendritic Cells to Perform Multiple Effector FunctionsThe Journal of Immunology, 2008
- CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cellsBlood, 2006